vaccines tagged posts

AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery

Illustration of a colorful virus particle breaking apart, representing an AI-designed universal vaccine targeting rapidly mutating virus variants.
(Image Credit: Corona Borealis Studio/Shutterstock)

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.

The trial, involving 39 healthy volunteers, tested a vaccine designed to provide protection against multiple Sarbeco coronaviruses—the large group of viruses that occur in nature including SARS-CoV-2, which caused the COVID pandemic.

The vaccine triggered immune responses in the volunteers not only to SARS-CoV-2 and SARS, but to related bat viruses that could potentially jump from animals to humans and cause future pandemics.

This trial proves the safety of an entirely new way of designing vaccines...

Read More

Injectable Hydrogel could someday lead to more effective Vaccines

Abstract Image
Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity

Vaccines have curtailed the spread of several infectious diseases, such as smallpox, polio and measles. However, vaccines against some diseases, including HIV-1, influenza and malaria, don’t work very well, and one reason could be the timing of antigen and adjuvant presentation to the immune system. Now, researchers reporting in ACS Central Science developed an injectable hydrogel that allows sustained release of vaccine components, increasing the potency, quality and duration of immune responses in mice.

To confer resistance to infectious diseases, vaccines display parts of a pathogen – known as antigens – to cells of the immune system, which develop antibodies against these molecules...

Read More

10 Million Lives Saved by 1962 Breakthrough, study says

S. J. Olshansky, L. Hayflick. The Role of the WI-38 Cell Strain in Saving Lives and Reducing Morbidity. AIMS Public Health, 2017; 4 (2): 127 DOI: 10.3934/publichealth.2017.2.127 Credit: National Cancer Institute

S. J. Olshansky, L. Hayflick. The Role of the WI-38 Cell Strain in Saving Lives and Reducing Morbidity. AIMS Public Health, 2017; 4 (2): 127 DOI: 10.3934/publichealth.2017.2.127 Credit: National Cancer Institute

Nearly 200 million cases of polio, measles, mumps, rubella, varicella, adenovirus, rabies and hepatitis A – and ~450,000 deaths from these diseases – were prevented in the U.S. alone between 1963 and 2015 by vaccination. The study is published in AIMS Public Health. In 1963, vaccination against these infections became widespread, thanks to the development of a human cell strain that allowed vaccines to be produced safely. Globally, the vaccines developed from this strain and its derivatives prevented an ~4.5 billion cases of disease and saved more than 10 million lives.

Author S...

Read More